Can you tell me the fda approval date for keytruda's overall cancer indication?

What is the FDA approval date for Keytruda’s overall cancer indication?

Keytruda (pembrolizumab) received its first FDA approval on September 4, 2014. [1]

This date is the approval “start” for Keytruda as an FDA-approved anti-cancer therapy, before later approvals expanded its labeled indications across multiple cancers and settings. [1]

Why you might see different dates for “overall” indications

Keytruda’s labeling has expanded over time through multiple FDA supplemental approvals for specific cancers, biomarkers, and treatment lines. That means searches for “Keytruda approval date” sometimes return different dates depending on whether you mean:
- the first FDA approval of the drug (September 4, 2014), or
- a later approval for a particular cancer type or regimen.

Source

[1] https://www.drugpatentwatch.com/p/keytruda-pembrolizumab/